AA
IDXX icon

AlphaCentric Advisors’s Idexx Laboratories IDXX Stock Holding History

AlphaCentric Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-137
Closed -$85K – 247
2021
Q3 		$85K Hold
137
– – 0.02% 172
2021
Q2 		$87K Buy
137
+17
+14% +$9.39K 0.02% 181
2021
Q1 		$59K Sell
120
-4
-3% -$2K 0.02% 181
2020
Q4 		$62K Buy
+124
New +$55.5K 0.03% 169

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AlphaCentric Advisors's IDXX Position: Q4 2021 in Review

AlphaCentric Advisors sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 137 shares — an estimated $85K sold.

AlphaCentric Advisors first reported a position in IDXX in Q4 2020 and held it in 4 quarters. The position peaked at $87K in Q2 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • AlphaCentric Advisors reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • AlphaCentric Advisors sold 137 Idexx Laboratories shares in Q4 2021, an estimated $85K.
  • AlphaCentric Advisors first reported a position in Idexx Laboratories in Q4 2020 and held it in 4 quarters.
  • AlphaCentric Advisors's Idexx Laboratories position peaked at $87K in Q2 2021.
  • 1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on AlphaCentric Advisors's 13F filing for Q4 2021, filed 25 Feb 2022.